Skip to content
HowShorted

COLLEGIUM PHARMACEUTICAL, INC short interest in 2025

In 2025, COLLEGIUM PHARMACEUTICAL, INC's disclosed short interest ran from 17.41% of shares outstanding on 15 Jan 2025 to 17.13% on 31 Dec 2025, a change of -0.28 percentage points. The year's high was 18.59% on 28 Nov 2025 and its low 13.09% on 15 Jul 2025, averaging 15.72% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.68 days on 30 May 2025. Full history: COLLEGIUM PHARMACEUTICAL, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for COLLEGIUM PHARMACEUTICAL, INC in 2025

2025 in figures

Start of year
17.41% (15 Jan 2025)
End of year
17.13% (31 Dec 2025)
Change
-0.28 pp
High
18.59% (28 Nov 2025)
Low
13.09% (15 Jul 2025)
Average
15.72%
Highest days to cover
19.68 (30 May 2025)
SEC filings marked
8

Every report in 2025

COLLEGIUM PHARMACEUTICAL, INC short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202517.41%10.66
31 Jan 202518.04%15.63
14 Feb 202516.54%17.41
28 Feb 202517.19%14.3610-K filed, results (8-K)
14 Mar 202516.73%12.95
31 Mar 202514.39%9.00
15 Apr 202514.21%9.61
30 Apr 202514.18%16.28
15 May 202515.79%14.4710-Q filed, results (8-K)
30 May 202515.26%19.68
13 Jun 202514.98%17.94
30 Jun 202513.55%13.62
15 Jul 202513.09%14.22
31 Jul 202513.38%16.50
15 Aug 202514.03%8.9410-Q filed, results (8-K)
29 Aug 202513.73%11.32
15 Sep 202514.14%8.78
30 Sep 202516.47%13.59
15 Oct 202516.61%16.34
31 Oct 202517.01%17.58
14 Nov 202517.97%7.6110-Q filed, results (8-K)
28 Nov 202518.59%11.40
15 Dec 202516.94%10.18
31 Dec 202517.13%11.69

See also: COLLEGIUM PHARMACEUTICAL, INC's full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.